Merck: Top Stock for Long-Term Growth
This is a U.S. news story, published by Yahoo Finance, that relates primarily to Nvidia news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsNvidia news
For more Nvidia news, you can click here:
more Nvidia newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
largest pharmaceutical companies. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest potential cancer medicine news, largest drugmakers news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cancer drugsThe Motley Fool
•Health
Health
Why This Beaten-Down Stock Is a Buy in 2025 and Beyond
78% Informative
Merck 's Keytruda generates over $20 billion in sales annually , an incredibly rare feat for a medicine.
While it will lose patent protection in 2028 , it should continue to grow its revenue until then.
Merck has earned more than 30 indications in the U.S. alone across various types of cancer.
It will take a while for ivonescimab to prove its worth in clinical trials across all these indications.
The Motley Fool Stock Advisor analyst team identified what they believe are the 10 best stocks for investors to buy now and Merck wasn’t one of them.
The 10 stocks that made the cut could produce monster returns in the coming years .
Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 874,051 !.
VR Score
74
Informative language
71
Neutral language
22
Article tone
formal
Language
English
Language complexity
45
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
9
Source diversity
3
Affiliate links
no affiliate links
Small business owner?